Marino, Stram & Associates LLC Bristol Myers Squibb CO Transaction History

Marino, Stram & Associates LLC

$407 Million
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $8,336 - $9,321	-144 Reduced 2.64%	5,304 $307,000
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $254 - $282	4 Added 0.07%	5,448 $348,000
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $1,774 - $2,012	27 Added 0.5%	5,444 $377,000
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $100,186 - $118,634	-1,463 Reduced 21.26%	5,417 $0
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $9 - $5,455	71 Added 1.04%	6,880 $489,000
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $1,016 - $1,119	-14 Reduced 0.21%	6,809 $524,000
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $11,927 - $14,301	-194 Reduced 2.76%	6,823 $498,000
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $23,811 - $27,758	-444 Reduced 5.95%	7,017 $437,000
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $779,446 - $913,020	-13,173 Reduced 63.84%	7,461 $441,000
Q2 2021 Jul 22, 2021	BUY	$61.91 - $67.42 $853,800 - $929,789	13,791 Added 201.53%	20,634 $1.38 Million
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $17,327 - $19,488	-292 Reduced 4.09%	6,843 $432,000
Q4 2020 Jan 19, 2021	BUY	$57.74 - $65.43 $76,505 - $86,694	1,325 Added 22.81%	7,135 $443,000
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $10,567 - $11,709	184 Added 3.27%	5,810 $350,000
Q2 2020 Jul 20, 2020	BUY	$54.82 - $64.09 $48,789 - $57,040	890 Added 18.79%	5,626 $331,000
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $87,649 - $127,375	-1,889 Reduced 28.51%	4,736 $264,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $42,960 - $56,037	873 Added 15.18%	6,625 $425,000
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $45,721 - $54,208	-1,069 Reduced 15.67%	5,752 $292,000
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $26,013 - $28,765	-583 Reduced 7.87%	6,821 $309,000
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $9,610 - $11,459	213 Added 2.96%	7,404 $353,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $2,925 - $3,793	-60 Reduced 0.83%	7,191 $374,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $2,373 - $2,676	-43 Reduced 0.59%	7,251 $450,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $8,337 - $10,391	-165 Reduced 2.21%	7,294 $404,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $8,089 - $9,312	135 Added 1.84%	7,459 $472,000
Q4 2017 Mar 09, 2018	BUY	$59.94 - $65.35 $439,000 - $478,623	7,324	7,324 $449,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.

Account